Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview

Highlights • Viral vector vaccines and VLPs have emerged as new platforms for vaccine design. • Viral vector vaccines show high efficacy and rapid onset of protection. • Viral vectors facilitate the rapid response to new variants and emerging viruses. • Many human recombinant vaccine candidates are based on adenovirus and lentivirus.